Get started
Author

Katelijne De Nys

Observed names: De Nys, Katelijne, K. De Nys, Katelijne de Nys
OpenAlex ID: A5055702587
Mitochondrial and peroxisomal targeting of 2-methylacyl-CoA racemase in humans
2000 · Leen Amery, Mark Fransen, et al. · Journal of Lipid Research · 106
PDF
Does Estrogen Receptor–Negative/Progesterone Receptor–Positive Breast Carcinoma Exist?
2008 · Leen De Maeyer, Erik Van Limbergen, et al. · Journal of Clinical Oncology · 105
An individualized digital twin of a patient for transdermal fentanyl therapy for chronic pain management
2023 · Flora Bahrami, René Michel Rossi, et al. · Drug Delivery and Translational Research · 50
PDF
The Neuronal Migration Defect in Mice with Zellweger Syndrome (Pex5Knockout) is not Caused by the Inactivity of Peroxisomal β-Oxidation
2002 · M. Baes, P. Gressens, et al. · Journal of Neuropathology & Experimental Neurology · 48
Market access of cancer drugs in European countries: improving resource allocation
2013 · Kim Pauwels, Isabelle Huys, et al. · Targeted Oncology · 41
Sponsorship in non-commercial clinical trials: definitions, challenges and the role of Good Clinical Practices guidelines
2015 · Raffaella Ravinetto, Katelijne De Nys, et al. · BMC International Health and Human Rights · 27
PDF
A European approach to clinical investigator training
2013 · Jean-Marie Boeynaems, Cindy Canivet, et al. · Frontiers in Pharmacology · 24
PDF
It is time to revise the international Good Clinical Practices guidelines: recommendations from non-commercial North–South collaborative trials
2016 · Raffaella Ravinetto, Halidou Tinto, et al. · BMJ Global Health · 22
PDF
Characterisation of human peroxisomal 2,4-dienoyl-CoA reductase1The sequence was deposited in the EMBL database (AJ293009).12During the preparation of this manuscript, the sequence of clone LA61-359F1 was finalised (AL023881 version 24) and an ORF was deduced which was identical to the cloned pDCR cDNA.2
2001 · Katelijne De Nys, Els Meyhi, et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 19
Predictors for reimbursement of oncology drugs in Belgium between 2002 and 2013
2015 · Kim Pauwels, Isabelle Huys, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 13
Geriatric evaluation methods in oncology and their use in clinical studies: A systematic literature review
2023 · Amelie Stueger, Markus Joerger, et al. · Journal of Geriatric Oncology · 11
PDF
Is personal physiology-based rapid prediction digital twin for minimal effective fentanyl dose better than standard practice: a pilot study protocol
2024 · Milena Cukic, Simon Annaheim, et al. · BMJ Open · 10
PDF
Implementing physics-based digital patient twins to tailor the switch of oral morphine to transdermal fentanyl patches based on patient physiology
2024 · Flora Bahrami, René Michel Rossi, et al. · European Journal of Pharmaceutical Sciences · 8
PDF
‘We need a physician who is a human being too’: exploration of barriers and facilitators for hospitalised palliative patients and their families to discuss advance care planning
2019 · Birgit Vanderhaeghen, Inge Bossuyt, et al. · International Journal of Palliative Nursing · 8
How often did Belgian physicians co-prescribe tamoxifen with strong CYP2D6 inhibitors over the last 6 years?
2014 · A. S. Dieudonné, K. De Nys, et al. · Acta Clinica Belgica · 6
Cloning and functional expression of human peroxisomal 2,4-dienoyl-CoA reductase
2001 · K. De Nys, E. Meyhi, et al. · Biochemical Society Transactions · 1
Challenges in palliative care for refugees
2025 · Elmira Wieser, Katelijne de Nys · BMJ Case Reports
SIOG2024-4-P-098 The lack of a standardized geriatric evaluation tool in studies investigating systemic anti-cancer treatments. A systematic literature review
2024 · K. De Nys, A. Stueger, et al. · Journal of Geriatric Oncology
[Pain therapy in palliative care].
2024 · Mirjam Buschor-Bichsel, Andrea Berendes, et al. · PubMed
Challenges and threats of investigator-initiated multicenter randomized controlled trials: the BACE trial experience
2019 · Kristina Vermeersch, Bénédicte Demeyere, et al. · International Journal of Clinical Trials
PDF
EMA maakt klinisch onderzoek transparanter
2015 · Gert Laekeman, Katelijne De Nys
Terugbetaling van geneesmiddelen in België
2015 · Katelijne De Nys · Leuven University Press eBooks
Markttoegang van kankergeneesmiddelen: procedures voor prijszetting en terugbetaling in Europese landen
2014 · Kim Pauwels, Isabelle Huys, et al. · Onco
Market Access of Cancer Drugs in European Countries: A Matter of Setting Priorities for Resource Allocation
2013 · K. Pauwels, I. Huys, et al. · Value in Health
Nationale consensusvergadering (met updating) over het gebruk van de derde-generatie aromatase-inhibitoren bij borstkanker
2004 · M. Casteels, Marie-Rose Christiaens, et al.
Works count: 28
Citation count: 499
H-index: 11
I10-index: 12
Year
Topic
Type